Curis Lifesciences Limited

Fast-Moving Consumer Goods (FMCG) | Rs. 2,56,000 Min Investment

Issue Opening Date
November 7, 2025
Issue Closing Date
November 11, 2025
Price Band
Rs 120 to Rs 128 per share
Lot Size
1,000 Shares
Curis Lifesciences Limited ClosedOpen
Fast-Moving Consumer Goods (FMCG)

Rs. 2,56,000

Min. investment
Invest Now

1. Company Information

Incorporated in 2010, Curis Lifesciences Limited is a pharmaceutical company that specializes in developing, manufacturing, and distributing a diverse range of products. The company manufactures pharmaceutical products globally and domestically on a loan license or contract basis, as well as for its own brand marketing. The company serves over 100 corporate clients on loan licenses or contract manufacturing and 2 clients for its own brand marketing in Yemen and Kenya. Products: General pharmaceutical tablets and capsules Oral liquids External preparations Sterile ophthalmic ointments The company operates a state-of-the-art manufacturing facility in Sanand, Gujarat, adhering to stringent quality control measures to ensure product safety and efficacy.

2. Competitive Strengths

Experienced Promoters and Management Team
Wide range of Products
Strategic Location of Manufacturing Facility
Scalable Business Model
Quality assurance

3.Curis Lifesciences Limited  Registrar

MUFG Intime India Pvt.Ltd.

+91-22-4918 6270
curislifesciences.smeipo@in.mpms.mufg.com
https://linkintime.co.in/Initial_Offer/public-issues.html

Curis Lifesciences Limited Details

Issue Opening Date November 7, 2025
Issue Closing Date November 11, 2025
Face Value Rs 10  per share
Price Rs 120 to Rs 128 per share
Lot Size 1,000 Shares
Sale Type Fresh Capital
Issue Size 21,50,000 shares (aggregating up to Rs 27.52 Cr)
Reserved for Market Maker 1,08,000 shares (aggregating up to Rs 1.38 Cr)
Net Offered to Public 20,42,000 shares (aggregating up to Rs 26.14 Cr)
Issue Type Bookbuilding IPO
Listing At NSE SME

Curis Lifesciences Limited Timeline (Tentative Schedule)

Event Tentative Date
Opening Date Fri, Nov 7, 2025
Closing Date Tue, Nov 11, 2025
Tentative Allotment Wed, Nov 12, 2025
Initiation of Refunds Thu, Nov 13, 2025
Credit of Shares to Demat Thu, Nov 13, 2025
Listing Date Fri, Nov 14, 2025
Cut-off time for UPI mandate confirmation 5 PM on Tue, Nov 11, 2025

Curis Lifesciences Limited Financial Information (Restated)

Period Ended
Total Assets
Total Revenue
Profit After Tax
EBITDA
Net Worth
Reserves and Surplus
Total Borrowing
31-Mar-25
42.53
49.65
6.11
9.54
16.23
10.29
15.62
31-Mar-24
33.88
35.87
4.87
8.39
5.87
5.37
17.09
31-Mar-23
29.75
36.42
1.88
3.28
1.01
0.51
16.19
Amount in Rs. Crore

Prospectus Document

Official Red Herring Prospectus (RHP)

For detailed company and issue information

Disclaimer: This report has been prepared by RR Equity Brokers Private Ltd. The information in this report is collected from various public sources. RR Equity Brokers is not responsible for any loss or damage that may result from using this information or from investment risks.

SEBI Registration No: NSE Cash: INB231219636 | SEBI Registration No: NSE Derivative: INF231219636 | SEBI Registration No: BSE Cash: INB011219632 | SEBI Registration No: MCX-SX: INE261219636 | SEBI Registration No: NSE Currency: INE231219636 | SEBI Registration No: USE: INE271219631 | SEBI Registration No: CDSL: IN-DP-CDSL-3242005 | NCDEX Membership No: 00635 | MCX Membership No: 28850 | NSEL Membership No: 10650 | RBI Registration No: NBFC: N-14.03215 | IRDA Registration Number : CB-066/03 | AMFI Registration No : ARN -0032| SEBI Registration No: Merchant Banker: INM000007508

* Mutual fund investments are subject to market risks. Please read the scheme information and other related documents carefully before investing.